Redcare Pharmacy - Public Comps and Valuation Multiples

Redcare Pharmacy Overview

About Redcare Pharmacy

Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue from the DACH segment, which represents income generated from Germany, Austria, and Switzerland. The International segment represents its income generated from Belgium, the Netherlands, France, and Italy.

Founded

2015

HQ

Employees

2.7K+

Website

redcare-pharmacy.com

Sectors

Pharmacies
Vertical E-commerce
Consumer E-commerce
HealthTech

Financials

LTM Revenue $3.3B

LTM EBITDA $67.4M

EV

$2.1B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Redcare Pharmacy Financials

As of September 2025, Redcare Pharmacy reported last 12-month revenue of $3.3B and EBITDA of $67.4M.

In the same period, Redcare Pharmacy generated $782M in LTM gross profit and -$28.5M in net income.

See Redcare Pharmacy valuation multiples based on analyst estimates

Redcare Pharmacy P&L

In the most recent fiscal year, Redcare Pharmacy reported revenue of $2.7B and EBITDA of $32.6M.

Redcare Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Redcare Pharmacy valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$3.3B	XXX	$2.7B	XXX	XXX	XXX
Gross Profit	$782M	XXX	$631M	XXX	XXX	XXX
Gross Margin	24%	XXX	23%	XXX	XXX	XXX
EBITDA	$67.4M	XXX	$32.6M	XXX	XXX	XXX
EBITDA Margin	2%	XXX	1%	XXX	XXX	XXX
EBIT	-$16.0M	XXX	-$45.1M	XXX	XXX	XXX
EBIT Margin	0%	XXX	-2%	XXX	XXX	XXX
Net Profit	-$28.5M	XXX	-$52.6M	XXX	XXX	XXX
Net Margin	-1%	XXX	-2%	XXX	XXX	XXX
Net Debt	XXX	XXX	$133M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Redcare Pharmacy including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $3.3B. EBITDA for the last twelve months was $67.4M. In the most recent fiscal year, Redcare Pharmacy achieved $2.7B in revenue and $32.6M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$3.3B	Analyst estimates available to subscribers	$2.7B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$782M	Analyst estimates available to subscribers	$631M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	23.7% gross margin	Analyst estimates available to subscribers	23.0% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$67.4M	Analyst estimates available to subscribers	$32.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	2.0% EBITDA margin	Analyst estimates available to subscribers	1.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$16.0M	Analyst estimates available to subscribers	-$45.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-0.5% EBIT margin	Analyst estimates available to subscribers	-1.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$28.5M	Analyst estimates available to subscribers	-$52.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-0.9% net profit margin	Analyst estimates available to subscribers	-1.9% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$133M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Redcare Pharmacy

This financial data table provides comprehensive performance metrics for Redcare Pharmacy, a company based in Germany. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Redcare Pharmacy generated $3.3B in revenue over the last twelve months.
The company achieved $67.4M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $782M.
Net income over the last twelve months reached -$28.5M.

Fiscal Year Performance

In the most recent fiscal year, Redcare Pharmacy reported $2.7B in total revenue.
Fiscal year EBITDA was $32.6M.
The company maintained a gross profit margin of 23.0% in the most recent fiscal year.
EBITDA margin for the fiscal year was 1.2%.
Net profit margin reached -1.9% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Redcare Pharmacy. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Redcare Pharmacy Stock Performance

Redcare Pharmacy has current market cap of EUR 1.8B (or $2.0B), and EV of EUR 1.8B (or $2.1B).

Market Cap Evolution

Redcare Pharmacy Stock Data

As of October 17, 2025, Redcare Pharmacy's stock price is EUR 87 (or $101).

See Redcare Pharmacy trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.1B	$2.0B	XXX	XXX	XXX	XXX	$-1.43

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Redcare Pharmacy Valuation Multiples

Redcare Pharmacy's trades at 0.8x EV/Revenue multiple, and 64.8x EV/EBITDA.

See valuation multiples for Redcare Pharmacy and 15K+ public comps

Redcare Pharmacy Financial Valuation Multiples

As of October 17, 2025, Redcare Pharmacy has market cap of $2.0B and EV of $2.1B.

Equity research analysts estimate Redcare Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Redcare Pharmacy has a P/E ratio of -71.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$2.0B	XXX	$2.0B	XXX	XXX	XXX
EV (current)	$2.1B	XXX	$2.1B	XXX	XXX	XXX
EV/Revenue	0.6x	XXX	0.8x	XXX	XXX	XXX
EV/EBITDA	31.3x	XXX	64.8x	XXX	XXX	XXX
EV/EBIT	-131.9x	XXX	-46.8x	XXX	XXX	XXX
EV/Gross Profit	2.7x	XXX	n/a	XXX	XXX	XXX
P/E	-71.2x	XXX	-38.6x	XXX	XXX	XXX
EV/FCF	-69.5x	XXX	-91.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Redcare Pharmacy Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Redcare Pharmacy Margins & Growth Rates

Redcare Pharmacy's last 12 month revenue growth is 21%

Redcare Pharmacy's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.3M for the same period.

Redcare Pharmacy's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Redcare Pharmacy's rule of X is 55% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Redcare Pharmacy and other 15K+ public comps

Redcare Pharmacy Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	21%	XXX	23%	XXX	XXX	XXX
EBITDA Margin	2%	XXX	1%	XXX	XXX	XXX
EBITDA Growth	84%	XXX	13%	XXX	XXX	XXX
Rule of 40	24%	XXX	22%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	55%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$1.0M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	13%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	25%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial